CC Quote, Financials, Valuation and Earnings

Quaker Houghton has a net margin of -0.57% compared to The Chemours's net margin of 3.19%. The Chemours's return on equity of 12.49% beat Quaker Houghton's return on equity of 8.36%.

The Chemours has a consensus price target of $19.90, signalling upside risk potential of 76.42%. On the other hand Quaker Houghton has an analysts' consensus of $167.50 which suggests that it could grow by 55.05%. Given that The Chemours has higher upside potential than Quaker Houghton, analysts believe The Chemours is more attractive than Quaker Houghton.

The Chemours has a beta of 1.839, which suggesting that the stock is 83.857% more volatile than S&P 500. In comparison Quaker Houghton has a beta of 1.438, suggesting its more volatile than the S&P 500 by 43.848%.

The Chemours has a quarterly dividend of $0.25 per share corresponding to a yield of 8.87%. Quaker Houghton offers a yield of 1.78% to investors and pays a quarterly dividend of $0.49 per share. The Chemours pays 172.09% of its earnings as a dividend. Quaker Houghton pays out 28.44% of its earnings as a dividend. Quaker Houghton's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but The Chemours's is not.

The Chemours quarterly revenues are $1.4B, which are larger than Quaker Houghton quarterly revenues of $444.1M. The Chemours's net income of -$8M is lower than Quaker Houghton's net income of $14.2M. Notably, The Chemours's price-to-earnings ratio is 20.14x while Quaker Houghton's PE ratio is 16.29x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours is 0.29x versus 1.03x for Quaker Houghton. Usually stocks with elevated PS ratios are considered overvalued.

Minerals Technologies has a net margin of -0.57% compared to The Chemours's net margin of 10.42%. The Chemours's return on equity of 12.49% beat Minerals Technologies's return on equity of 9.71%.

The Chemours has a consensus price target of $19.90, signalling upside risk potential of 76.42%. On the other hand Minerals Technologies has an analysts' consensus of $101.00 which suggests that it could grow by 79.46%. Given that Minerals Technologies has higher upside potential than The Chemours, analysts believe Minerals Technologies is more attractive than The Chemours.

The Chemours has a beta of 1.839, which suggesting that the stock is 83.857% more volatile than S&P 500. In comparison Minerals Technologies has a beta of 1.249, suggesting its more volatile than the S&P 500 by 24.905%.

The Chemours has a quarterly dividend of $0.25 per share corresponding to a yield of 8.87%. Minerals Technologies offers a yield of 0.75% to investors and pays a quarterly dividend of $0.11 per share. The Chemours pays 172.09% of its earnings as a dividend. Minerals Technologies pays out 7.9% of its earnings as a dividend. Minerals Technologies's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but The Chemours's is not.

The Chemours quarterly revenues are $1.4B, which are larger than Minerals Technologies quarterly revenues of $518.1M. The Chemours's net income of -$8M is lower than Minerals Technologies's net income of $54M. Notably, The Chemours's price-to-earnings ratio is 20.14x while Minerals Technologies's PE ratio is 10.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours is 0.29x versus 0.86x for Minerals Technologies. Usually stocks with elevated PS ratios are considered overvalued.

Ingevity has a net margin of -0.57% compared to The Chemours's net margin of 5.56%. The Chemours's return on equity of 12.49% beat Ingevity's return on equity of -113.59%.

The Chemours has a consensus price target of $19.90, signalling upside risk potential of 76.42%. On the other hand Ingevity has an analysts' consensus of $49.75 which suggests that it could grow by 55.66%. Given that The Chemours has higher upside potential than Ingevity, analysts believe The Chemours is more attractive than Ingevity.

The Chemours has a beta of 1.839, which suggesting that the stock is 83.857% more volatile than S&P 500. In comparison Ingevity has a beta of 1.544, suggesting its more volatile than the S&P 500 by 54.443%.

The Chemours has a quarterly dividend of $0.25 per share corresponding to a yield of 8.87%. Ingevity offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Chemours pays 172.09% of its earnings as a dividend. Ingevity pays out -- of its earnings as a dividend.

The Chemours quarterly revenues are $1.4B, which are larger than Ingevity quarterly revenues of $298.8M. The Chemours's net income of -$8M is lower than Ingevity's net income of $16.6M. Notably, The Chemours's price-to-earnings ratio is 20.14x while Ingevity's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours is 0.29x versus 0.83x for Ingevity. Usually stocks with elevated PS ratios are considered overvalued.

Rayonier Advanced Materials has a net margin of -0.57% compared to The Chemours's net margin of -3.84%. The Chemours's return on equity of 12.49% beat Rayonier Advanced Materials's return on equity of -5.27%.

The Chemours has a consensus price target of $19.90, signalling upside risk potential of 76.42%. On the other hand Rayonier Advanced Materials has an analysts' consensus of $11.00 which suggests that it could grow by 135.04%. Given that Rayonier Advanced Materials has higher upside potential than The Chemours, analysts believe Rayonier Advanced Materials is more attractive than The Chemours.

The Chemours has a beta of 1.839, which suggesting that the stock is 83.857% more volatile than S&P 500. In comparison Rayonier Advanced Materials has a beta of 2.861, suggesting its more volatile than the S&P 500 by 186.088%.

The Chemours has a quarterly dividend of $0.25 per share corresponding to a yield of 8.87%. Rayonier Advanced Materials offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Chemours pays 172.09% of its earnings as a dividend. Rayonier Advanced Materials pays out -- of its earnings as a dividend.

The Chemours quarterly revenues are $1.4B, which are larger than Rayonier Advanced Materials quarterly revenues of $422.5M. The Chemours's net income of -$8M is higher than Rayonier Advanced Materials's net income of -$16.2M. Notably, The Chemours's price-to-earnings ratio is 20.14x while Rayonier Advanced Materials's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours is 0.29x versus 0.19x for Rayonier Advanced Materials. Usually stocks with elevated PS ratios are considered overvalued.